Immunovant shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.3M | 150k | 42.13 |
| 2023-09-30 | $9.5M | 247k | 38.39 |
| 2023-06-30 | $2.8M | 148k | 18.97 |
| 2023-03-31 | $968k | 62k | 15.51 |
| 2022-12-31 | $465k | 26k | 17.75 |
| 2022-09-30 | $102k | 18k | 5.56 |
| 2022-03-31 | $246k | 45k | 5.51 |
| 2021-12-31 | $1.3M | 155k | 8.52 |
| 2021-09-30 | $678k | 78k | 8.69 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management